Abstract
Abnormal movements have been associated with the administration of selective serotonin reuptake inhibitors (SSRIs) ( Bouchard et al., 1989 Bouchard RH Pourcher E Vincent P Fluoxetine and extrapyramidal side effects. Am J Psychiatry. 1989; 146: 1352-1353 Google Scholar ; Gerber and Lynd, 1998 Gerber PE Lynd LD Selective serotonin reuptake inhibitor-induced movement disorders. Ann Pharmacother. 1998; 32: 692-698 Crossref PubMed Scopus (220) Google Scholar ; Jones-Fearing, 1996 Jones-Fearing KB SSRI and EPS with fluoxetine. J Am Acad Child Adolesc Psychiatry. 1996; 35: 1107-1108 Abstract Full Text PDF PubMed Scopus (11) Google Scholar ; Lauterbach et al., 1997 Lauterbach EC Meyer JM Simpson GM Clinical manifestations of dystonia and dyskinesia after SSRI administration. J Clin Psychiatry. 1997; 58: 403-404 Crossref PubMed Scopus (6) Google Scholar ; Raphael, 1996 Raphael JL Movement disorders associated with the serotonin reuptake inhibitors. J Clin Psychiatry. 1996; 57: 449-454 Crossref PubMed Scopus (332) Google Scholar ). Gerber and Lynd, 1998 Gerber PE Lynd LD Selective serotonin reuptake inhibitor-induced movement disorders. Ann Pharmacother. 1998; 32: 692-698 Crossref PubMed Scopus (220) Google Scholar identified 127 published reports of SSRI-induced movement disorders in adults. In contrast, only one case of extrapyramidal symptoms (EPS) secondary to an SSRI has been reported in adolescents. In that case, acute dystonia developed 4 days after the initiation of fluoxetine ( Jones-Fearing, 1996 Jones-Fearing KB SSRI and EPS with fluoxetine. J Am Acad Child Adolesc Psychiatry. 1996; 35: 1107-1108 Abstract Full Text PDF PubMed Scopus (11) Google Scholar ). We now describe the case of an adolescent patient who developed acute dystonia following administration of the SSRI citalopram.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
